| B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) (NCT04897321) | St. Jude Children's Research Hospital | 2022-07-06 |
| A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577) (NCT05266196) | Salarius Pharmaceuticals, LLC | 2022-01-15 |
| Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors (NCT04901806) | Pyramid Biosciences | 2021-07-20 |
| Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group (NCT03967834) | Institut Claudius Regaud | 2021-04-26 |
| Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor (NCT04616560) | National Cancer Institute (NCI) | 2021-03-08 |
| Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor (NCT04690374) | Memorial Sloan Kettering Cancer Center | 2020-12-22 |
| Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults (NCT04530487) | M.D. Anderson Cancer Center | 2020-08-19 |
| B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT04483778) | Seattle Children's Hospital | 2020-07-13 |
| CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor (NCT04145349) | Eli Lilly and Company | 2020-01-22 |
| Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease (NCT01125449) | Situs Cancer Research Center | 2020-01-01 |
| A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum (NCT04022213) | Memorial Sloan Kettering Cancer Center | 2019-07-15 |
| EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults (NCT03618381) | Seattle Children's Hospital | 2019-06-18 |
| Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas (NCT03600649) | Salarius Pharmaceuticals, LLC | 2018-06-04 |
| A Phase II of Nivolumab Plus Ipilimumab in Non-resectable Sarcoma and Endometrial Carcinoma (NCT02982486) | Assaf-Harofeh Medical Center | 2017-12-01 |
| Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors (NCT02982941) | MacroGenics | 2016-12-01 |
| Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell Tumors (NCT01946529) | St. Jude Children's Research Hospital | 2013-12-27 |
| French National Registry of Rare Peritoneal Surface Malignancies (NCT02834169) | Hospices Civils de Lyon | 2010-10-01 |